Profile data is unavailable for this security.
About the company
Shionogi & Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company is mainly engaged in the research and development, purchasing, manufacturing, sales, and related activities of ethical pharmaceuticals. The Company is engaged in research and development, purchasing, manufacturing, and marketing of pharmaceuticals for the treatment of gram-negative bacterial infections, influenza virus infections, new coronavirus infections, invasive aspergillus infections, complicated urinary tract infections including pyelonephritis, Alzheimer's disease, chronic pain, cancer of the esophagus, bladder, head and neck, solid tumors, and other diseases. The Company provides products and services in Japan, Europe, North America, and other regions.
- Revenue in JPY (TTM)465.35bn
- Net income in JPY194.86bn
- Incorporated1919
- Employees4.96k
- LocationShionogi & Co Ltd3-1-8, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
- Phone+81 662022161
- Fax+81 662299596
- Websitehttps://www.shionogi.com/jp/
More ▼
Mergers & acquisitions
| Acquired company | 4507:TYO since announced | Transaction value |
|---|---|---|
| Japan Tobacco Inc-Pharmaceutical Business | 39.11% | 37.90m |
Data delayed at least 15 minutes, as of Mar 04 2026 06:30 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sumitomo Pharma Co Ltd | 453.40bn | 110.09bn | 779.49bn | 3.83k | 7.07 | 2.69 | 5.92 | 1.72 | 277.11 | 277.11 | 1,141.22 | 727.28 | 0.5438 | 1.95 | 3.99 | 118,318,100.00 | 13.20 | -5.49 | 23.02 | -8.49 | 59.24 | 67.88 | 24.28 | -13.24 | 1.01 | 4.17 | 0.4726 | -- | 26.79 | -3.75 | 107.50 | -10.32 | -0.4856 | -- |
| Ono Pharmaceutical Co Ltd | 509.35bn | 62.40bn | 1.24tn | 4.29k | 18.74 | 1.39 | 12.49 | 2.44 | 132.76 | 132.76 | 1,084.01 | 1,786.88 | 0.4702 | 2.14 | 3.38 | 118,811,500.00 | 5.77 | 10.78 | 6.61 | 12.37 | 69.79 | 73.23 | 12.27 | 21.23 | 2.56 | 125.26 | 0.1283 | 36.33 | -3.14 | 10.73 | -60.89 | -3.47 | -18.66 | 12.20 |
| Kyowa Kirin Co Ltd | 496.83bn | 67.04bn | 1.44tn | 5.67k | 21.32 | 1.60 | 15.41 | 2.89 | 128.07 | 128.07 | 949.13 | 1,706.50 | 0.4568 | 1.82 | 2.99 | -- | 6.16 | 6.40 | 7.33 | 7.37 | 74.25 | 74.99 | 13.49 | 14.37 | 2.35 | -- | -- | 46.19 | 0.2559 | 9.31 | 11.98 | 7.35 | 19.80 | 7.10 |
| Eisai Co Ltd | 808.19bn | 42.76bn | 1.45tn | 13.51k | 32.86 | 1.58 | 17.36 | 1.80 | 151.67 | 151.67 | 2,866.61 | 3,153.46 | 0.5537 | 0.7996 | 3.33 | 59,839,040.00 | 3.04 | 3.81 | 4.22 | 5.14 | 77.75 | 77.47 | 5.48 | 6.44 | 1.54 | -- | 0.2015 | 98.01 | 6.42 | 2.56 | 9.49 | -17.54 | -14.48 | 0.00 |
| Shionogi & Co Ltd | 465.35bn | 194.86bn | 3.11tn | 4.96k | 15.27 | 1.97 | 14.41 | 6.69 | 228.94 | 228.94 | 546.70 | 1,779.33 | 0.2869 | 0.8648 | 2.76 | 93,915,640.00 | 11.98 | 12.17 | 13.13 | 13.74 | 84.50 | 84.91 | 41.78 | 38.30 | 5.21 | -- | 0.0148 | 27.87 | 0.7325 | 5.62 | 5.19 | 6.88 | 34.66 | 12.30 |
| Astellas Pharma Inc | 2.06tn | 322.91bn | 4.34tn | 13.64k | 13.36 | 2.44 | 8.44 | 2.11 | 179.57 | 179.57 | 1,145.43 | 984.21 | 0.5841 | 1.27 | 2.90 | 151,038,200.00 | 9.15 | 3.05 | 14.11 | 4.45 | 81.00 | 81.15 | 15.67 | 5.42 | 0.839 | 41.32 | 0.2913 | 131.42 | 19.25 | 8.01 | 197.72 | -23.64 | -5.94 | 13.09 |
| Daiichi Sankyo Co Ltd | 2.05tn | 304.60bn | 5.38tn | 19.77k | 17.35 | 3.07 | 14.20 | 2.62 | 163.62 | 163.62 | 1,103.05 | 924.09 | 0.5649 | 0.8183 | 3.11 | 103,827,400.00 | 8.38 | 5.72 | 10.55 | 7.11 | 77.54 | 72.15 | 14.84 | 11.03 | 1.85 | -- | 0.1495 | 49.57 | 17.77 | 13.95 | 44.47 | 17.77 | 29.01 | 20.79 |
| Otsuka Holdings Co Ltd | 2.47tn | 363.15bn | 5.50tn | 35.34k | 14.79 | 1.76 | 11.41 | 2.23 | 685.26 | 685.26 | 4,657.43 | 5,743.73 | 0.6221 | 2.08 | 4.57 | 69,865,070.00 | 9.23 | 5.91 | 11.37 | 7.27 | 71.68 | 69.18 | 14.83 | 9.89 | 1.67 | -- | 0.0685 | 32.93 | 15.42 | 10.78 | 182.13 | 21.96 | 15.32 | 3.71 |
| Takeda Pharmaceutical Co Ltd | 4.46tn | 112.93bn | 9.11tn | 47.46k | 79.26 | 1.18 | 10.59 | 2.04 | 72.26 | 72.26 | 2,834.46 | 4,838.54 | 0.2926 | 1.17 | 6.17 | 94,080,250.00 | 0.7418 | 1.71 | 0.8772 | 2.04 | 65.33 | 67.66 | 2.54 | 5.99 | 0.6548 | 3.49 | 0.3884 | 123.75 | 7.45 | 6.84 | -25.08 | 19.53 | 9.82 | 1.72 |
Data as of Mar 04 2026. Currency figures normalised to Shionogi & Co Ltd's reporting currency: Japanese Yen JPY
27.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 05 Feb 2026 | 52.11m | 5.86% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 28.90m | 3.25% |
| BlackRock Fund Advisorsas of 31 Dec 2024 | 28.61m | 3.22% |
| Amova Asset Management Co., Ltd.as of 15 Sep 2025 | 25.73m | 2.89% |
| Daiwa Asset Management Co. Ltd.as of 30 Jan 2026 | 24.40m | 2.74% |
| Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025 | 21.82m | 2.45% |
| BlackRock Japan Co. Ltd.as of 31 Dec 2024 | 16.75m | 1.88% |
| Wellington Management Co. LLPas of 30 Jan 2026 | 16.47m | 1.85% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Feb 2026 | 14.13m | 1.59% |
| Geode Capital Management LLCas of 26 Feb 2026 | 11.99m | 1.35% |
More ▼
Data from 31 Dec 2025 - 26 Feb 2026Source: FactSet Research Systems Inc.
